Article Versions Notes

Pitarch-Castellano I, Ñungo-Garzón NC, Aragon-Gawińska K, Ibáñez-Albert E, Vázquez-Costa JF, Sevilla T. Neurofilaments as Biomarkers of the Efficacy of Risdiplam Treatment in Early SMA Phenotypes Diagnosed by Newborn Screening. Children. 2025; 12(9):1170. https://doi.org/10.3390/children12091170

Pitarch-Castellano, Inmaculada, Nancy Carolina Ñungo-Garzón, Karolina Aragon-Gawińska, Eugenia Ibáñez-Albert, Juan F. Vázquez-Costa, and Teresa Sevilla. 2025. "Neurofilaments as Biomarkers of the Efficacy of Risdiplam Treatment in Early SMA Phenotypes Diagnosed by Newborn Screening" Children 12, no. 9: 1170. https://doi.org/10.3390/children12091170

Pitarch-Castellano, I., Ñungo-Garzón, N. C., Aragon-Gawińska, K., Ibáñez-Albert, E., Vázquez-Costa, J. F., & Sevilla, T. (2025). Neurofilaments as Biomarkers of the Efficacy of Risdiplam Treatment in Early SMA Phenotypes Diagnosed by Newborn Screening. Children, 12(9), 1170. https://doi.org/10.3390/children12091170